CAMBRIDGE, Mass.--(BUSINESS WIRE)--Millennium: The Takeda Oncology Company today announced abstracts from studies involving six molecules in the Company’s portfolio have been accepted for presentation at the annual meeting of the American Society of Hematology (ASH) to be held December 4–7, 2010 in Orlando, Florida. The abstracts include oral presentations across a spectrum of hematologic malignancies.
